XML 55 R36.htm IDEA: XBRL DOCUMENT v3.25.0.1
Share-Based Payment Arrangements (Tables)
12 Months Ended
Dec. 28, 2024
Amounts Recognized in Financial Statements with Respect to Plans Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):
 
    
Fiscal Years
 
    
2024
    
2023
    
2022
 
Total cost of the Plans during the period
   $ 3,435      $ 4,282      $ 12,399  
Amount of related income tax benefit recognized during the period
     (1,963      (3,622      (5,199
  
 
 
    
 
 
    
 
 
 
Net cost of the Plans during the period
   $ 1,472      $ 660      $ 7,200  
  
 
 
    
 
 
    
 
 
 
Schedule of Information on Restricted Stock Units
The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans:

 
  
Number of
RSUs
 
 
Weighted Average

Grant Date
Fair Value
 
Outstanding at December 25, 2021
     209,399      $ 102.90  
Granted
     50,019      $ 139.44  
Shares earned in excess of target
(1)
     91,497      $ 92.58  
Vested shares, including shares earned in excess of target
     (177,146    $ 95.48  
Forfeited
     (21,989    $ 113.85  
  
 
 
    
Outstanding at December 31, 2022
     151,780      $ 115.80  
Granted
     41,638      $ 164.91  
Shares earned in excess of target
(2)
     79,176      $ 98.39  
Vested shares, including shares earned in excess of target
     (137,861    $ 97.97  
Forfeited
     (2,011    $ 142.67  
  
 
 
    
Outstanding at December 30, 2023
     132,722      $ 138.93  
Granted
     102,997      $ 138.85  
Shares earned in excess of target
(3)
     1,791      $ 51.42  
Vested shares, including shares earned in excess of target
     (45,057    $ 115.69  
Forfeited
     (29,801    $ 140.20  
  
 
 
    
Outstanding at December 28, 2024
     162,652      $ 144.12  
  
 
 
    

(1)
Represents additional shares earned under each of the February 2, 2017, February 2, 2018 and February 1, 2019 RSU awards, as fiscal year 2021 financial results exceeded target performance level under each such award.
(2)
Represents additional shares earned (i) under the February 1, 2019 and January 31, 2020 RSU awards as fiscal year 2022 financial results exceeded target performance level and (ii) under the April 24, 2018 and July 1, 2019 RSU awards as total shareholder return during the applicable performance period exceeded target performance level under each of those awards.
(3)
Represents additional shares earned under the April 24, 2018 and July 1, 2019 RSU awards as total shareholder return during the applicable performance period exceeded target performance level under each of those awards.
Schedule of Information on Non-Vested Restricted Stock and Deferred Stock Units
The following table summarizes information regarding the Company’s outstanding shares of
non-vested
restricted stock and Deferred Stock Units (defined below) under the Plans:
 
    
Number of

Shares and Deferred

Stock Units
    
Weighted Average
Grant Date

Fair Value
 
Non-vested
at December 25, 2021
     56,436      $ 125.16  
Granted
     25,354      $ 152.54  
Vested
     (27,074    $ 122.68  
Forfeited
     (6,921    $ 144.45  
  
 
 
    
Non-vested
at December 31, 2022
     47,795      $ 138.30  
Granted
     22,714      $ 179.32  
Vested
     (24,161    $ 138.35  
  
 
 
    
Non-vested
at December 30, 2023
     46,348      $ 158.38  
Granted
     31,525      $ 187.08  
Vested
     (25,647    $ 151.16  
Forfeited
     (4,707    $ 169.92  
  
 
 
    
Non-vested
at December 28, 2024
     47,519      $ 180.17  
  
 
 
    
Summary of Information Regarding Stock Options
The following table summarizes information regarding the Company’s outstanding stock options under the Plans for fiscal years 2023 and 2022:
 
    
Options Outstanding
    
Options Exercisable
 
    
Number of

Options
    
Weighted Average

Exercise Price

per Share
    
Number of

Options
    
Weighted Average

Exercise Price

per Share
 
Options at December 25, 2021
     8,570      $ 55.42        8,570      $ 55.42  
Exercised
     (6,670    $ 55.14        
  
 
 
          
Options at December 31, 2022
     1,900      $ 56.40        1,900      $ 56.40  
Exercised
     (1,900    $ 56.40        
  
 
 
          
Options at December 30, 2023
     —            —